secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beam Therapeutics Inc. (BEAM)
CIK:        0001745999
Form:       8-K
Filed at:   2026-03-05T23:59:59+00:00
Accession:  0001193125-26-093914
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Beam terminates license pact with Bio Palette; Kobe University standby license activated
--------------------------------------------------------------------------------

- Mutual termination of License Agreement with Bio Palette effective March 2, 2026 due to Bio Palette's planned dissolution.
- Standby License Agreement with Kobe University activated, granting Beam exclusive license to base editing patents previously covered.
- No future payments due between Beam and Bio Palette under the Termination Agreement or License Agreement.
- Beam retains rights to exploit base editing technology for human disease worldwide, minus microbiome field in Asia.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1745999/000119312526093914/0001193125-26-093914-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1745999/000119312526093914/beam-20260302.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-093914

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer